Publications by authors named "Lisa A Ware"

Claim this Profile
L
Low-dose dengue virus 3 human challenge model: a phase 1 open-label study.
Adam T Waickman, Krista Newell, Joseph Q Lu, HengSheng Fang, Mitchell Waldran, Lisa A Ware

Nat Microbiol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy.
Jason W Bennett, Anjali Yadava, Donna Tosh, Jetsumon Sattabongkot, Jack Komisar, Lisa A Ware

PLoS Negl Trop Dis· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.
James F Cummings, Michele D Spring, Robert J Schwenk, Christian F Ockenhouse, Kent E Kester, Lisa A Ware

Vaccine· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A.
Michele D Spring, James F Cummings, Christian F Ockenhouse, Sheetij Dutta, Randall Reidler, Lisa A Ware

PLoS One· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Process development for the production of an E. coli produced clinical grade recombinant malaria vaccine for Plasmodium vivax.
Brian A Bell, James F Wood, Reeta Bansal, Hatem Ragab, John Cargo, Lisa A Ware

Vaccine· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone.
V Ann Stewart, Shannon M McGrath, Patrice M Dubois, Maria G Pau, Pascal Mettens, Lisa A Ware

Infect Immun· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.
Mark E Polhemus, Alan J Magill, James F Cummings, Kent E Kester, Chris F Ockenhouse, Lisa A Ware

Vaccine· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites.
Anjali Yadava, Jetsumon Sattabongkot, Michael A Washington, Lisa A Ware, Victoria Majam

Infect Immun· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Murine immune responses to liver-stage antigen 1 protein FMP011, a malaria vaccine candidate, delivered with adjuvant AS01B or AS02A.
Clara Brando, Lisa A Ware, Helen Freyberger, April Kathcart, Arnoldo Barbosa

Infect Immun· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02A.
V Ann Stewart, Shannon M McGrath, Douglas S Walsh, Stacey Davis, Aaron S Hess, Lisa A Ware

Vaccine· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Merozoite surface protein 1 of Plasmodium vivax induces a protective response against Plasmodium cynomolgi challenge in rhesus monkeys.
Sheetij Dutta, Deep C Kaushal, Lisa A Ware, Sunil K Puri, Nuzhat A Kaushal

Infect Immun· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Process development and analysis of liver-stage antigen 1, a preerythrocyte-stage protein-based vaccine for Plasmodium falciparum.
Collette J Hillier, Lisa A Ware, Arnoldo Barbosa, Evelina Angov, Jeffrey A Lyon

Infect Immun· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum.
Sheetij Dutta, J David Haynes, Arnoldo Barbosa, Lisa A Ware, Jeffrey D Snavely

Infect Immun· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.
D Gray Heppner, Kent E Kester, Christian F Ockenhouse, Nadia Tornieporth, Opokua Ofori, Lisa A Ware

Vaccine· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production of the subdomains of the Plasmodium falciparum apical membrane antigen 1 ectodomain and analysis of the immune response.
P V Lalitha, Lisa A Ware, Arnoldo Barbosa, Sheetij Dutta, J Kathleen Moch

Infect Immun· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli.
Sheetij Dutta, P V Lalitha, Lisa A Ware, Arnoldo Barbosa, J Kathleen Moch

Infect Immun· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis